Genetic polymorphisms were also found to affect the levels of brain-derived neurotrophic factor (BDNF), dopamine, and apolipoprotein E (APOE), which in their turn affect neuroplasticity, functional recovery, and the type of stroke [14]. The gene discussed is APOE; the disease is stroke disorder.